tradingkey.logo
搜索

NeuroOne Medical Technologies Corp

NMTC
添加自选
3.000USD
-0.040-1.32%
收盘 07/01, 16:00美东报价延迟15分钟
25.85M总市值
亏损市盈率 TTM

NeuroOne Medical Technologies Corp

3.000
-0.040-1.32%

关于 NeuroOne Medical Technologies Corp 公司

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

NeuroOne Medical Technologies Corp简介

公司代码NMTC
公司名称NeuroOne Medical Technologies Corp
上市日期Nov 09, 2012
CEORosa (David A)
员工数量17
证券类型Ordinary Share
年结日Nov 09
公司地址7599 Anagram Dr
城市EDEN PRAIRIE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编55344-7399
电话19524261383
网址https://nmtc1.com/
公司代码NMTC
上市日期Nov 09, 2012
CEORosa (David A)

NeuroOne Medical Technologies Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%
Mr. Ronald (Ron) Mcclurg
Mr. Ronald (Ron) Mcclurg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher R. Volker
Mr. Christopher R. Volker
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Emily Johns
Ms. Emily Johns
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Chris Donovan
Mr. Chris Donovan
Investor Relations
Investor Relations
--
--
名称
名称/职务
职务
持股
持股变动
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%

常见问题

NeuroOne Medical Technologies Corp的前五大股东是谁?

NeuroOne Medical Technologies Corp 的前五大股东如下:Mr. David A. (Dave) Rosa

有多少机构持有NeuroOne Medical Technologies Corp(NMTC)的股份?

截至2026Q1,共有58家机构持有NeuroOne Medical Technologies Corp的股份,合计持有的股份价值约为2.36M,占公司总股份的28.07%。与2025Q4相比,机构持股有所增加,增幅为-230396.00。